Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

NCT02684006

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Southern Cancer Center Daphne, Alabama, United States
  • Southern Cancer Center Mobile, Alabama, United States
  • Southern Cancer Center Mobile, Alabama, United States
  • Tower Hematology Oncology Medical Group Beverly Hills, California, United States
View all 270 locations
View Trial Details
Completed

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

NCT04306900

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +34 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Clinical Trials Office Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 32 locations
View Trial Details
Completed

A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)

NCT05524545

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusett's General Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Completed

Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)

NCT02553642

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +19 more
Locations
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

NCT05902494

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • University of California Irvine Orange, California, United States
  • Stanford Cancer Institute - School of Medicine Palo Alto, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 23 locations
View Trial Details

Related conditions